Science
Mechanism of Action
This ingredient operates as a peptide-based compound, designed to signal and activate the skin's endogenous repair mechanisms. Peptides are generally understood to stimulate regeneration in mature skin, reinforce its structural integrity, and visibly diminish the appearance of wrinkles, thereby contributing to an improved complexion and enhanced elasticity. While its minoxidil component is known to influence blood flow and collagen production, the specific actions of this derivative on skin are broadly categorized as 'SKIN CONDITIONING'.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Safety
Safety Profile
MINOXIDIL SUCCINOYL DECAPEPTIDE-18 has not been reviewed by regulatory bodies such as CIR, SCCS, or FDA. The European Commission's CosIng database advises considering regulatory provisions applicable to minoxidil, indicating potential scrutiny due to its medicinal status. Independent assessments from sources like Paula's Choice and Sinaí Estética currently label it as 'Not rated' or 'being reviewed', citing no known benefits at this time.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While conceptually interesting as a peptide derivative for skin conditioning, the current absence of comprehensive safety data, regulatory clarity, and established clinical efficacy means its utility in precision skincare formulations remains unsupported.
Related
Similar Ingredients
Finding similar ingredients…